By Richard Pagliaro | Monday, December 22, 2025
Photo credit: Battle of Boca Instagram
Jessica Eudovic has been provisionally suspended for violating tennis’ anti-doping protocal.
The 18-year-old American submitted a urine sample that contained the banned substance clostebol at a drug test conducted at the ITF World Tennis Tour W15 event in Santa Tecla, El Salvador, on October 1st, the International Tennis Integrity Agency announced today.
Here’s the ITIA’s statement detailing Eudovic’s positive test and subsequent provisional suspension:
The sample was split into A and B samples and the subsequent analysis found that both samples contained a metabolite of clostebol, which is prohibited under the TADP, in the category of Anabolic Androgenic Steroids (section S1.1 of the 2025 World Anti-Doping Agency Prohibited List).
Clostebol is a non-Specified substance, and Eudovic did not possess a valid TUE for the substance.
Findings for non-Specified Substances carry a mandatory provisional suspension – in Eudovic’s case, this has been in effect from 21 November 2025.
Eudovic, who reached a career-high ITF singles ranking of 1104 in October 2025, filed an appeal of her provisional suspension on December 1st.
However, that appeal was dismissed on December 16th by independent chair Dr Tanja Haug, who declared that the basis of Eudovic’s appeal was “insufficient to meet the threshold required to lift a Provisional Suspension.”
While provisionally suspended, Eudovic is prohibited from playing in, coaching at, or attending any tennis event authorized or sanctioned by the members of the ITIA (ATP, ITF, WTA, Tennis Australia, Fédération Française de Tennis, Wimbledon and USTA) or any national association.
